Updated Acne Management Guidelines by the American Academy of Dermatology Association

Updated Acne Vulgaris Clinical Guideline by the American Academy of Dermatology Association

Introduction:

Acne vulgaris, a prevalent skin condition characterized by clogged hr follicles due to excessive sebum production and dead skin cells, is one of the most common diseases globally, impacting approximately 85 of adolescents and often persisting into adulthood. Beyond just a skin condition, acne can significantly influence mental health, causing social isolation, depression, and in extreme cases, suicidality. The American Academy of Dermatology Association has continuously updated its guidelines on acne management with the latest findings to improve patient outcomes.

Acne Resource Center for Patients:

The AAD offers an extensive Acne Resource Center med at educating patients and their caregivers about effective treatment strategies for acne care. This resource is designed to provide accurate, up-to-date information on various treatments avlable for managing both adolescent and adult acne effectively.

Key Recommations from the Acne Vulgaris Clinical Guideline:

1. Topical Therapies:

   • Benzoyl peroxide: Recommed as a first-line treatment due to its ability to kill bacteria and reduce inflammation.

   • Topical retinoids: Often recommed for their role in preventing clogged pores, reducing redness, and speeding up skin cell turnover.

   • Topical antibiotics: Used to control bacterial growth on the skin surface without increasing antibiotic resistance when used appropriately as a second-line treatment.

   • Clascoterone: A newer topical treatment that combines anti-androgenic properties with benefits for acne management.

   • Salicylic acid: Recommed for its keratolytic effects and ability to unclog pores.

   • Azelc acid: Noted for its antimicrobial, anti-inflammatory, and skin lightening effects.

2. Systemic Therapies:

   • Doxycycline: A first-generation tetracycline antibiotic often used in combination with topical therapies due to minimal side effects and broad-spectrum activity agnst acne-causing bacteria.

   • Minocycline: Recommed for patients who are allergic to doxycycline, offering similar efficacy but potentially fewer gastrointestinal side effects.

   • Sarecycline: A newer tetracycline derivative, noted for its reduced potential for antibiotic resistance.

   • Combined oral contraceptives: Considered for female patients with severe or resistant acne, especially when hormonal imbalance is suspected as a contributing factor.

   • Spironolactone: Often used in combination with other therapies due to its androgen-blocking properties, which help reduce sebum production.

3. Systemic Antimicrobial Use:

The guideline recomms limiting the use of systemic antibiotics as primary treatment for acne unless there is evidence of significant bacterial colonization or resistance to topical treatments. It emphasizes combining systemic antibiotic therapy with topical benzoyl peroxide or other complementary therapies to enhance efficacy and minimize adverse effects.

4. Good Clinical Practices:

• advocate utilizing combination products that target multiple aspects of acne e.g., anti-inflammatory, antibacterial, keratolytic for improved outcomes.

• Limiting the use of systemic antibiotics while integrating these with topical treatments like benzoyl peroxide or retinoids to synergize their benefits and reduce antibiotic exposure.

• The integration of adjuvant intralesional corticosteroid injections as an option for severe inflammatory acne lesions, particularly when topical and oral therapies are insufficient.

:

The updated guidelines by the American Academy of Dermatology Association provide comprehensive recommations on the management of acne vulgaris. By emphasizing evidence-based practices, such as a combination approach to therapy and judicious use of systemic treatments, these guidelines m to enhance patient outcomes while considering the potential mental health impacts associated with acne. The Acne Resource Center serves as an additional tool for patients seeking educational resources on managing their condition effectively.

: This information is provided for general reference only. For specific medical advice or treatment recommations, please consult a qualified healthcare professional.

About AAD:

The American Academy of Dermatology Association AAD is dedicated to advancing the field of dermatology through research, education, and advocacy for its members and patients. With resources for members and support for various initiatives in public health and patient care, the AAD works tirelessly to promote excellence in dermatological sciences.

For more information on membership options, meetings and educational programs, practice management strategies, clinical guidelines, publications, career development opportunities, and advocacy efforts, visit the AAD website or contact the organization directly. Stay connected with the latest updates through social media platforms like Instagram, Twitter, and Facebook.

To learn about corporate partnerships, licensing agreements, exhibitor information for the annual meeting, press releases for media engagement, international initiatives, public education campgns, website feedback mechanisms, and to explore career opportunities within the dermatology field, refer to the specific pages on the AAD website or contact their customer service department.

For inquiries related to employment opportunities, store items, donations, preferred vors, terms of use, privacy policies, or corporate sponsors supporting dermatological research and patient care, please consult the respective sections on the official website. Your feedback is crucial for improving the quality and effectiveness of online resources provided by the AAD.

All rights reserved ? 2024 American Academy of Dermatology Association. Unauthorized reproduction or republication is strictly prohibited without prior written permission from the organization.

your suggestions, concerns, or comments through contact forms, mling lists, or directly to customer service representatives for further assistance and inquiries.
This article is reproduced from: https://www.aad.org/member/clinical-quality/guidelines/acne

Please indicate when reprinting from: https://www.zy47.com/Acne_Hospital/Acne_Vulgarity_Guideline_Overview.html